Amplia Therapeutics (ASX: ATX) makes headway in anti-cancer clinical trial (w/ Mark Devlin)

Small Caps - A podcast by Small Caps

Amplia Therapeutics (ASX: ATX) chief scientific officer Mark Devlin joins Small Caps to discuss the latest achievements made in the...